Okay.
Dr. Tunis, you spoke earlier in your testimony about AstraZeneca, and you were talking about the dosing interval.
For the average Canadian and putting it in regular-speak, you were talking about that effectiveness being extended or some studies showing that. Can you maybe explain that without some of the medical terms and actually explain what that means for the average Canadian who got the AstraZeneca dose?